Remains on track to name a development candidate for a novel first-in-class neurology program targeting demyelinating diseases in 2026Progresses discovery work on a best-in-class cell therapeutic ...
The field of cancer immunology has witnessed dramatic progress with the advent of immunotherapies targeting the tumor immune microenvironment (TIME).
Anthropocene Magazine on MSN
A new kind of green revolution could start with self-fertilizing crops
Early experiments in barley suggest that reprogramming plant immune receptors could one day slash the world’s dependence on ...
Using a blend of computer modeling, structural and cell-based studies, scientists at The Wertheim UF Scripps Institute have ...
Morning Overview on MSN
Scientists found a safer path to boost calorie-burning cells
For decades, weight loss drugs have tried to coax the body into burning more energy, but the most aggressive approaches have ...
STORM Therapeutics Ltd. (STORM), the clinical stage company pioneering cellular reprogramming through RNA modifications to treat disease, ...
While metabolomics is the large-scale comprehensive profiling of metabolites and other small molecules in the context of ...
Fundamental Cure for Intractable and Incurable Diseases using ‘Biological Age Zero’ Cells Derived from Patient’s Own Cells via SCNT TechnologyWorld's First Therapy Platform Simultaneously Solving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback